Our most interesting finding was that about 30% of our BCM patients on active therapy showed significantly high frequencies of IFN-γ-producing S-specific TCM and TEM CD4+ and CD8+ T lymphocytes (HR patients). The gene discussed is IFNG; the disease is blue cone monochromacy.